Tech International, Inc. – Trademark Portfolio
Entity Type: 03
Tech International, Inc. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include CLEAR CHOICE and SUB-SOLUTION. The owner is based in Macon, GA.
4731 Northside Drive
Macon, GA 31210
Showing of trademarks Trademarks
Trademark Classifications
Tech International, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does Tech International, Inc. have?
Tech International, Inc. has 9 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned, 5 cancelled.
What trademark classes does Tech International, Inc. file in?
Tech International, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Tech International, Inc.'s most well-known trademarks?
Tech International, Inc.'s registered trademark portfolio includes well-known marks such as CLEAR CHOICE and SUB-SOLUTION. These are among 3 currently registered trademarks in the portfolio.
What is Tech International, Inc.'s trademark registration success rate?
Tech International, Inc. has a 33% trademark registration rate, with 3 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.